Matches in Wikidata for { <http://www.wikidata.org/entity/Q70285006> ?p ?o ?g. }
Showing items 1 to 41 of
41
with 100 items per page.
- Q70285006 description "article scientifique publié en 1986" @default.
- Q70285006 description "artículu científicu espublizáu en marzu de 1986" @default.
- Q70285006 description "im März 1986 veröffentlichter wissenschaftlicher Artikel" @default.
- Q70285006 description "scientific article published on 01 March 1986" @default.
- Q70285006 description "wetenschappelijk artikel" @default.
- Q70285006 description "наукова стаття, опублікована в березні 1986" @default.
- Q70285006 name "Effect of L-threo-3,4-dihydroxyphenylserine chronic administration on cerebrospinal fluid and plasma free 3-methoxy-4-hydroxy-phenylglycol concentration in patients with Parkinson's disease" @default.
- Q70285006 name "Effect of L-threo-3,4-dihydroxyphenylserine chronic administration on cerebrospinal fluid and plasma free 3-methoxy-4-hydroxy-phenylglycol concentration in patients with Parkinson's disease" @default.
- Q70285006 type Item @default.
- Q70285006 label "Effect of L-threo-3,4-dihydroxyphenylserine chronic administration on cerebrospinal fluid and plasma free 3-methoxy-4-hydroxy-phenylglycol concentration in patients with Parkinson's disease" @default.
- Q70285006 label "Effect of L-threo-3,4-dihydroxyphenylserine chronic administration on cerebrospinal fluid and plasma free 3-methoxy-4-hydroxy-phenylglycol concentration in patients with Parkinson's disease" @default.
- Q70285006 prefLabel "Effect of L-threo-3,4-dihydroxyphenylserine chronic administration on cerebrospinal fluid and plasma free 3-methoxy-4-hydroxy-phenylglycol concentration in patients with Parkinson's disease" @default.
- Q70285006 prefLabel "Effect of L-threo-3,4-dihydroxyphenylserine chronic administration on cerebrospinal fluid and plasma free 3-methoxy-4-hydroxy-phenylglycol concentration in patients with Parkinson's disease" @default.
- Q70285006 P1433 Q70285006-662822CC-9220-4450-AF6D-AFA7631D37DB @default.
- Q70285006 P1476 Q70285006-E88CDF6B-C6E9-4DAA-85FD-7771E36809D0 @default.
- Q70285006 P2093 Q70285006-CAC3D127-A3F8-4BDD-A4AF-9AF0B000CC10 @default.
- Q70285006 P2093 Q70285006-CED534E1-75D6-415B-83B6-D725E30702EE @default.
- Q70285006 P2093 Q70285006-E22D23B7-59C8-49EA-A9D9-FFEB7D2DC8C2 @default.
- Q70285006 P304 Q70285006-5C7FA521-34A7-497C-9349-2EC6CC949CAF @default.
- Q70285006 P31 Q70285006-868CE527-DA6E-4679-B3A2-BEB4B7AC5A49 @default.
- Q70285006 P356 Q70285006-D0597DB7-49EB-49B3-AE19-663D44C55822 @default.
- Q70285006 P433 Q70285006-8216A745-490D-48BF-B380-8266232D2F68 @default.
- Q70285006 P478 Q70285006-A6DDD1CB-269A-478E-BCD7-84FA10B972BA @default.
- Q70285006 P577 Q70285006-A682BB99-D1C2-479B-88CD-F2C3C580C8DB @default.
- Q70285006 P698 Q70285006-F585B7D9-C878-456E-98E3-E258868F7916 @default.
- Q70285006 P921 Q70285006-5E08795C-7734-4E6F-B683-73DF50D2EA36 @default.
- Q70285006 P356 0022-510X(86)90061-4 @default.
- Q70285006 P698 3084714 @default.
- Q70285006 P1433 Q6296168 @default.
- Q70285006 P1476 "Effect of L-threo-3,4-dihydroxyphenylserine chronic administration on cerebrospinal fluid and plasma free 3-methoxy-4-hydroxy-phenylglycol concentration in patients with Parkinson's disease" @default.
- Q70285006 P2093 "H Ujike" @default.
- Q70285006 P2093 "M Yamamoto" @default.
- Q70285006 P2093 "N Ogawa" @default.
- Q70285006 P304 "39-44" @default.
- Q70285006 P31 Q13442814 @default.
- Q70285006 P356 "10.1016/0022-510X(86)90061-4" @default.
- Q70285006 P433 "1" @default.
- Q70285006 P478 "73" @default.
- Q70285006 P577 "1986-03-01T00:00:00Z" @default.
- Q70285006 P698 "3084714" @default.
- Q70285006 P921 Q11085 @default.